Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Ambulatory, APC, Arrangementsfor, Biotherapy, commented, configuration, court, covenant, creditor, decline, devalued, Entry, Eventsfor, extended, failure, geometric, hypothetical, hypothetically, inadequate, industry, installment, Ireland, irrevocable, irrevocably, Kingdom, Liabilitiesfor, lien, likelihood, macroeconomic, nonsurgical, prepay, provisional, restated, shipped, sinking, situation, supervised, thereto, thereunder, threshold, title, valuable, whichever
Removed:
conducted, tradename
Filing tables
Filing exhibits
Related press release
AURX similar filings
Filing view
External links
Exhibit 32.1
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. §1350 and in connection with the Quarterly Report on Form 10-Q of Nuo Therapeutics, Inc. (the “Company”) for the period ended September 30, 2015 (the “Report”), I, Dean Tozer, Chief Executive Officer of the Company, hereby certify, that, to my knowledge:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 12, 2015 | /s/ Dean Tozer | |
Dean Tozer | ||
Chief Executive Officer | ||
(Principal Executive Officer) |